In this episode, William Taranto, Founder and President of Merck’s Global Health Innovation Fund, shares his perspective on how strategic investments in AI, digital health, and data-driven technologies can address critical challenges across the pharmaceutical industry.
William explains why healthcare innovation must begin with real industry problems rather than individual technologies. He discusses the importance of building connected ecosystems, where data and complementary solutions work together to create value at scale. As AI accelerates drug discovery, he highlights the need for pharmaceutical companies to strengthen clinical development, manufacturing, and supply chain capabilities to keep pace.
The conversation also explores Merck’s approach to fostering innovation through strategic partnerships, commercial collaborations, and global investment initiatives. William emphasizes that successful healthcare innovation requires a deep understanding of the industry, patience to build sustainable businesses, and a clear focus on improving patient access and outcomes. Take a listen.
Terry Myerson leads a very interesting organization – Truveta – that’s trying to aggregate healthcare data from health systems across the country in a...
Neal Singh, CEO of Caradigm, discusses data, analytics, and population health management
In this episode, Dr. Colin Banas discusses how they are uniting different stakeholders in the healthcare space through their concept – HealthiverseTM – and...